Delivery Order SPE2DB20D9127-SPE2DB25FPRD1
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,293.72 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Botox 200 unit vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and does not utilize a set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Botox 200 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 5, 2025, and was awarded without any set-aside designation. Performance will take place at the vendor's Park Ridge, Illinois location....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,700.56 by the Defense Logistics Agency (DLA) for the supply of Botox 100 unit vials. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, was issued without a set-aside designation. The contract is performed at the contractor's facility in Park Ridge, Illinois, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $9,251.40 by the Defense Logistics Agency (DLA) on August 19, 2025. The delivery order calls for the supply of Botox 100-unit vials, with an ultimate completion date of September 10, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis. The Place of Performance is listed...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for BOTOX 200 unit vials valued at $7.76K by the Defense Logistics Agency (DLA) on August 18, 2025, with an ultimate completion date of September 9, 2025. The contract utilizes firm fixed-price pricing and does not employ a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,937.00 by the Defense Logistics Agency on August 14, 2025, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order is scheduled for ultimate completion by September 5, 2025, with performance taking place in Park Ridge, Illinois. The award carries no set-aside designation, allowing the vendor to compete on a full and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,938.55 by the Defense Logistics Agency on August 19, 2025, for the supply of Botox 100 Unit Vials. The contract, which carries an ultimate completion date of September 10, 2025, was issued without set-aside designation. This delivery order represents one of many pharmaceutical supply contracts DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,881.10 by the Defense Logistics Agency on August 14, 2025, for the supply of Botox 200 unit vials. The contract, which has no set-aside designation, is scheduled for completion by September 5, 2025, with performance taking place in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for BOTOX 200 Unit Vials with a ceiling value of $9,636.00. This firm fixed-price delivery order, which carries an ultimate completion date of August 25, 2025, represents a direct procurement without set-aside designation. The award leverages DMS Pharmaceutical Group's position as a crucial...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48,569.85 on August 18, 2025, for the supply of Botox 100 Unit Vials. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, is issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, which is valued at $499,999,999 and remains...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRD1Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $27,754.20 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Botox 100 unit vials. This firm fixed-price delivery order, with an ultimate completion date of September 5, 2025, was issued without a set-aside designation and represents execution under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The contractor will perform the delivery at its Park Ridge, Illinois location. This award is part of DMS Pharmaceutical Group's substantial $500 million IDC with the DLA under the SPE2DB program, which remains valid through November 2026. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group regularly delivers specialized medical products including prescription medications, biologics, and injectables to Department of Defense healthcare facilities nationwide. The company's established portfolio of pharmaceutical deliveries to military health systems and its consistent success in federal procurement demonstrate its operational capacity to fulfill the Department of Defense's pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.8k | 8/14/25 |